Fantao Meng
Chief Tech/Sci/R&D Officer at Hemoglobin Oxygen Therapeutics LLC
Profile
Fantao Meng is currently working as the Director of Research & Development at Hemoglobin Oxygen Therapeutics LLC.
He holds a doctorate degree from the Chinese Academy of Sciences.
Fantao Meng active positions
| Companies | Position | Start |
|---|---|---|
Hemoglobin Oxygen Therapeutics LLC
 Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Hemoglobin Oxygen Therapeutics LLC operates as a biotechnology company. It is focused on the development, manufacture and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. The firm’s products include Hemopure and Oxyglobin. The company was founded by Zafiris G. Zafirelis and Igor Serov on February 18, 2014 and is headquartered in Souderton, PA. | Chief Tech/Sci/R&D Officer | - |
Training of Fantao Meng
| Chinese Academy of Sciences | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Hemoglobin Oxygen Therapeutics LLC
Hemoglobin Oxygen Therapeutics LLC Pharmaceuticals: MajorHealth Technology Hemoglobin Oxygen Therapeutics LLC operates as a biotechnology company. It is focused on the development, manufacture and commercialization of a proprietary technology platform for oxygen-carrying solutions that address critical unmet medical needs in both human and veterinary medicine. The firm’s products include Hemopure and Oxyglobin. The company was founded by Zafiris G. Zafirelis and Igor Serov on February 18, 2014 and is headquartered in Souderton, PA. | Health Technology |
- Stock Market
- Insiders
- Fantao Meng
